Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 May 2008 16:16

Immunodiagnostic Systems Hldgs PLC02 May 2008 Immunodiagnostic Systems Holdings plc ("Immunodiagnostic " or "the Company") Directors' Dealings The Company was notified on 1 May 2008 of the following transaction. On 14 April 2008, Mrs. Hailes, wife of Paul Hailes (Finance Director), received6,396 ordinary 2p shares in the Company ("Shares") as a result of a transfer.Following this transfer, Paul Hailes has an interest of 928,046 Shares*representing 3.871% of the issued share capital of the Company. \* This includes 51,496 Shares held by Mrs. Hailes. Contact: Immunodiagnostic Systems Holdings plcDavid Evans, ChairmanTel: 07740 084 452 Oriel Securities Limited (Nominated Adviser)Andrew EdwardsGareth PriceTel: 020 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Apr 20057:01 amRNSResearch Agreement
21st Feb 200510:08 amRNSAcquisition
4th Feb 20054:30 pmRNSExercise of Options
18th Jan 20053:20 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.